PFOA and PFOS serum levels and miscarriage risk

Epidemiology

Volumn 25, Issue 4, 2014, Pages 505-512

  Darrow, Lyndsey A ^a   Howards, Penelope P ^a   Winquist, Andrea ^b   Steenland, Kyle ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANE;

ADULT; ANALYTIC METHOD; ARTICLE; BIRTH; BLOOD LEVEL; CONCEPTION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PREGNANCY; HUMAN; INTERVIEW; LIVE BIRTH; LOGISTIC REGRESSION ANALYSIS; MATERNAL CARE; POPULATION RISK; PREGNANCY OUTCOME; PRIMIGRAVIDA; PRIORITY JOURNAL; RISK ASSESSMENT; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; BLOOD; CHEMICALLY INDUCED; PREGNANCY; PROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADULT; CAPRYLATES; FEMALE; FLUOROCARBONS; HUMANS; LOGISTIC MODELS; ODDS RATIO; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84902248620     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000103     Document Type: Article

References (38)

1. US Environmental Protection Agency. Perfluorooctanoic Acid (PFOA) and Fluorinated Telomers. 2013. Available at: http://www.epa.gov/oppt/ pfoa/index.html. Accessed 17 December 2013.
2. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115:1596-1602.
3. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99:366-394.
4. Lau C, Thibodeaux JR, Hanson RG, et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci. 2006;90:510-518.
5. Darrow LA, Stein CR, Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010. Environ Health Perspect. 2013;121:1207-1213.
6. Fei C, Weinberg CR, Olsen J. Commentary: perfluorinated chemicals and time to pregnancy: a link based on reverse causation? Epidemiology. 2012;23:264-266.
7. Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod. 2009;24:1200-1205.
8. Savitz DA, Stein CR, Bartell SM, et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology. 2012;23:386-392.
9. Vestergaard S, Nielsen F, Andersson AM, et al. Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive. Hum Reprod. 2012;27: 873-880.
10. Whitworth KW, Haug LS, Baird DD, et al. Perfluorinated compounds and subfecundity in pregnant women. Epidemiology. 2012;23:257-263.
11. Buck Louis GM, Sundaram R, Schisterman EF, et al. Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect. 2013;121:231-236.
12. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118:686-692.
13. Winquist A, Steenland K. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology. 2014;25:255-264.
14. Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol. 2011;54:478-487.
15. van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17:605-619.
16. Steenland K, Jin C, MacNeil J, et al. Predictors of PFOA levels in a community surrounding a chemical plant. Environ Health Perspect. 2009;117:1083-1088.
17. Stein CR, Savitz DA, Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol. 2009;170:837-846.
18. Frisbee SJ, Brooks AP Jr, Maher A, et al. The C8 health project: design, methods, and participants. Environ Health Perspect. 2009;117:1873-1882.
19. Winquist A, Lally C, Shin HM, Steenland K. Design, methods, and population for a study of PFOA health effects among highly exposed mid- Ohio valley community residents and workers. Environ Health Perspect. 2013;121:893-899.
20. Fei C, McLaughlin JK, Tarone RE, Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect. 2007;115:1677-1682.
21. Fromme H, Mosch C, Morovitz M, et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol. 2010;44:7123-7129.
22. Flaherty JM, Connolly PD, Decker ER, et al. Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;819:329-338.
23. L ongnecker MP, Smith CS, Kissling GE, et al. An interlaboratory study of perfluorinated alkyl compound levels in human plasma. Environ Res. 2008;107:152-159.
24. Centers for Disease Control and Prevention. Available at: http://www. cdc.gov/healthyweight/assessing/bmi/adult-bmi/index.html#Interpreted. Accessed 30 January 2012.
25. Howards PP, Schisterman EF, Poole C, Kaufman JS, Weinberg CR. "Toward a clearer definition of confounding" revisited with directed acyclic graphs. Am J Epidemiol. 2012;176:506-511.
26. Weinberg CR. Toward a clearer definition of confounding. Am J Epidemiol. 1993;137:1-8.
27. Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect. 2010;118:222-228.
28. Brede E, Wilhelm M, Göen T, et al. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health. 2010;213:217-223.
29. Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 2007;115:1298-1305.
30. Zhang Y, Beesoon S, Zhu L, Martin JW. Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ Sci Technol. 2013;47:10619-10627.
31. Olsen GW, Lange CC, Ellefson ME, et al. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000- 2010. Environ Sci Technol. 2012;46:6330-6338.
32. Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding. Scand J Work Environ Health. 2010;36:413-421.
33. Buck Louis GM, Peterson CM, Chen Z, et al. Perfluorochemicals and endometriosis: the ENDO study. Epidemiology. 2012;23:799-805.
34. Brosens I, Brosens JJ, Fusi L, Al-Sabbagh M, Kuroda K, Benagiano G. Risks of adverse pregnancy outcome in endometriosis. Fertil Steril. 2012;98:30-35.
35. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340:1796-1799.
36. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29:507-513.
37. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708-1712.
38. Lang K, Nuevo-Chiquero A. Trends in self-reported spontaneous abortions: 1970-2000. Demography. 2012;49:989-1009.